EMH.V - Emerald Health Therapeutics, Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.9700
-0.1100 (-5.29%)
At close: 3:51PM EDT
Stock chart is not supported by your current browser
Previous Close2.0800
Open2.0800
Bid1.9700 x 0
Ask1.9800 x 0
Day's Range1.9500 - 2.0900
52 Week Range1.9500 - 5.9200
Volume616,798
Avg. Volume394,021
Market Cap282.839M
Beta (3Y Monthly)2.16
PE Ratio (TTM)N/A
EPS (TTM)-0.1960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.10
  • GlobeNewswire8 days ago

    Emerald Health Therapeutics’ New Organic Cannabis Operation Receives Cultivation License for Outdoor Grow Area

    OTCQX: EMHTF) has received its cultivation license from Health Canada for the 12-acre outdoor grow area at its new organic cannabis operation in Metro Vancouver, BC. The outdoor grow area is expected to be capable of producing approximately 10,000 kg of cannabis annually with multiple crops during a full growing season. With this license effective as of July 12, 2019, Emerald is positioned to deliver one harvest and a portion of the expected full production volume this year. The 12 acres (~500,000 square feet) of outdoor cultivation are part of an overall 20-acre site that includes 156,000 sq. ft. in two greenhouses.

  • GlobeNewswire12 days ago

    Emerald Health Therapeutics’ Joint Venture Achieves Its Full Annualized Production Run-Rate

    OTCQX: EMHTF) 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has achieved its full production run-rate of 75,000 kilograms of dried cannabis at its 1.1 million square foot Delta 3 greenhouse in Delta, British Columbia. “Pure Sunfarms’ growing operation is setting the standard for large-scale low cost high quality cannabis production, which we believe serves as a strong indication of what the combined expertise of Emerald and Village Farms can accomplish,” said Dr. Avtar Dhillon, Executive Chairman and President of Emerald.

  • GlobeNewswire13 days ago

    Emerald Health Therapeutics Expands Distribution of its SYNC 25 CBD Oil to Two More Canadian Provinces

    VANCOUVER, British Columbia, July 10, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has shipped 9,960 40-ml units of its SYNC 25 CBD oil to.

  • Baystreet14 days ago

    The Tech Company Transforming Cannabis Markets

    Some are ready to call it quits on the cannabis market. But the Green Revolution has only just gotten ...